DOSEGUY

Tranylcypromine

most data

Also seen as: Parnate

The Dose Guy’s verdict
Sep 1, 2026
4 sources

Tranylcypromine works. It beat placebo for depression, it beat tricyclics head-to-head, and for treatment-resistant depression the effect size is large. A separate meta-analysis of ten studies found it roughly equal to other antidepressants overall, so “most effective ever” depends on which slice of the data you read, but the treatment-resistant signal is genuinely strong. The drive and energy it gives are why some people in the nootropic space run it off-label. The catch is not the usual “thin data” warning. The catch is that this drug can kill you if you eat the wrong cheese or take the wrong pill. The tyramine diet is not a suggestion, and a serotonergic interaction can be fatal in a single dose. If you can manage the restrictions, this is a legitimate tool. If you cannot commit to them fully, the rest of this shelf carries nothing comparable, but at least it will not kill you over a meal.

Would I take it?Caution, real drug, real danger.

What it is

An irreversible, nonselective monoamine oxidase inhibitor. Tranylcypromine shuts down both MAO-A and MAO-B permanently, the enzymes that break down serotonin, norepinephrine, and dopamine. The result is more of all three sitting in the synapse longer, which is why it works for depression and why users describe a stimulant-like drive and clarity on top of the mood lift. The “irreversible” part is why the restrictions are so strict: once the enzyme is gone, your body has to build new MAO from scratch, and until it does, anything that floods those monoamine channels hits with no brake.

On this shelf it is the only approved nootropic-adjacent compound with deep clinical data. It is not a research chemical or a peptide experiment. It is a real drug with real efficacy, real side effects, and real fatality reports, and it belongs to the prescriber-and-patient relationship even when people source it otherwise.

What the research shows

The data behind tranylcypromine is deep, decades-long, and clear: it works for depression, it works better than most things for treatment-resistant depression, and the danger is documented just as thoroughly.

Meta-analysis of four controlled depression studies found tranylcypromine superior to placebo, log odds ratio 0.509, 95% CI 0.026 to 0.993.Eur Neuropsychopharmacol 2017 · meta-analysis
Head-to-head meta-analysis of eight prospective studies favored tranylcypromine over tricyclic antidepressants, log odds ratio 0.480, p=0.01.J Clin Psychopharmacol 2020 · meta-analysis
A patient on tranylcypromine developed fatal serotonin syndrome after a single erroneous dose of imipramine. One pill, one death. The interaction risk is not theoretical.case report 2003 · fatal interaction
A patient on tranylcypromine ate soft cheese and developed hypertensive crisis with chest pain, headache, and cardiac troponin release. The diet restriction is the price of entry.case report 2018 · tyramine crisis

Realistic protocols

The dose that matters here is the one you can hold without wrecking sleep. Titrate up based on response. The therapeutic range for depression is usually 30 to 60 mg/day, split into two or three doses, with the last dose early enough in the afternoon that sleep stays intact. Some people in the off-label space run lower doses, 10 to 20 mg/day, for the drive and focus effects without chasing a full antidepressant response. That lower range carries the same dietary and interaction restrictions.

The tyramine diet is non-negotiable. Aged cheese, cured meats, fermented foods, draft beer, soy sauce, sauerkraut: anything that concentrates tyramine becomes a potential hypertensive crisis trigger. Fresh foods are fine. The list is shorter than people think, but it is absolute. Alcohol is not banned outright, but the interaction blunts its metabolism and makes hangovers brutal, and certain wines and beers carry enough tyramine to be dangerous on their own.

The interaction list is the other wall. No SSRIs, no SNRIs, no tramadol, no dextromethorphan, no stimulants without careful medical management, no psilocybin, no MDMA. A serotonergic combination can trigger serotonin syndrome, which can be fatal. MAO recovery takes roughly two weeks after stopping, so the washout in both directions is long.

Start10 mg 2x/dayMorning and early afternoon. The standard clinical entry.
Therapeutic30–60 mg/daySplit 2–3 doses. Titrate by response over weeks, not days.
Off-label low10–20 mg/dayThe drive-and-focus range. This is still an MAOI. Same diet and interaction rules, no exceptions.
Washout~2 weeksMAO takes that long to rebuild. No serotonergic drugs in either direction.

Side effects

Well-documented, because this is a studied drug. The side profile is manageable if you respect the restrictions:

commonInsomnia, especially with afternoon dosing. Dose timing fixes most of it.
commonOrthostatic hypotension, dizziness on standing. More noticeable in the first weeks and at higher doses.
commonREM sleep takes a real hit. At an average 37 mg/day, one study measured a 40% reduction in REM time and nearly threefold longer REM latency. Dreams may disappear and sleep can feel less restorative even when you get enough hours.
monitorHypertensive crisis from tyramine or drug interaction. Sudden severe headache is the warning sign. This is a medical emergency, not a side effect to push through.

Where to buy

No live listings from tracked vendors right now.